Combined application of TNFα and TGFβ signatures moderately enhanced the correlation with neoadjuvant therapy responses but did not reach statistical significance (p=0.11) (Supplementary Fig.
← all excerpts
Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
1
0.1100
0.1100